Tuesday, November 8th, 2011
(Editor's note: I asked Arnie Friede, an attorney with expertise in FDA and social media regulatory matters, to offer some of his thoughts about these issues on a regular basis. He has obliged, and we'll be hearing from him again. You can also hear Arnie talk with Pharmalot Editor at ...
Posted in
Healthcare ad agencies, Legal actions, Promotional medical education, Social media in pharma, digital advertising |
1 Comment »
Wednesday, June 10th, 2009
Recently, FDA issued a draft guidance titled Presenting Risk Information in Prescription Drug and Medical Device Promotion. The draft guidance outlines factors FDA considers when evaluating ads and labeling for prescription drugs, providing examples to illustrate the agency’s thinking. According to FDA, the guidance was issued in response to requests ...
Posted in
FDA Files, Sales & Marketing |
1 Comment »
|
|
